Niagen Bioscience, Inc. — Director's Dealing 2010

Dec 15, 2010

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ChromaDex Corp. (CDXC.OB)
CIK: 0001386570
Period of Report: 2010-12-08

Reporting Person: Jaksch Frank L Jr (Director, CEO, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2010-12-08	Common Stock	P	5000	$1.50	Acquired	5000	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1429000	Indirect
Common Stock	6225155	Indirect

Footnotes

F1: Held by the Jaksch Family Trust (the "Trust") of which the Reporting Person is sole beneficiary. On April 17, 2010, the Reporting Person and the trustees of the Trust entered into an irrevocable proxy granting sole voting power over the Trust's shares to the Reporting Person.

F2: Held by Black Sheep, FLP, a California limited partnership, of which the Reporting Person and Tricia A. Jaksch are the sole co-general partners and the Reporting Person, Tricia A. Jaksch and the 2008 Jaksch Family Trust UTD June 25, 2008 (the "2008 Family Trust") are the sole limited partners. The Reporting Person and Tricia A. Jaksch are the trustees of the 2008 Family Trust.